| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 4,557,099 | 8,052,040 | 9,239,745 | 3,268,334.5* |
| Cost of revenue | 206,365 | 1,340,881 | 956,745 | 1,256,555.5* |
| Gross profit | 4,350,734 | 6,711,159 | 8,283,000 | 2,011,779* |
| Sales and marketing | 553,300 | 915,841 | 1,067,555 | 1,014,012* |
| Distribution costs | 588,652 | 924,201 | 887,596 | 593,743.5* |
| General and administrative | 4,931,678 | 5,522,786 | 9,257,208 | 8,896,950.25* |
| Unrealized loss on digital assets | 92,307,488 | -164,495,019 | NaN | NaN |
| Crypto asset, realized gain (loss), operating | NaN | -341,599 | NaN | NaN |
| Realized loss on digital asset revenue conversion to usd | 1,887,472 | NaN | NaN | NaN |
| Realized loss on sale of digital assets | 6,773,418 | NaN | NaN | NaN |
| Realized and unrealized (gain) loss on digital assets | NaN | NaN | NaN | 26,368.5* |
| Unrealized (gain) on digital assets | NaN | NaN | 77,996,124 | NaN |
| Stock-based compensation | 3,987,514 | 8,300,673 | 5,756,398 | 589,215.5* |
| Amortization of acquired intangible assets | 19,190 | 19,190 | 19,190 | 19,189.5* |
| Impairment on assets from manufacturing shut down | 0 | 1,422,289 | NaN | NaN |
| Depreciation | 88,289 | 134,388 | 135,902 | -9,700.5* |
| Impairment of long-lived asset - building | NaN | NaN | NaN | 0* |
| Loss on the sale / abandonment of assets in relocation | NaN | NaN | NaN | 0* |
| Impairment of intangible assets and goodwill | NaN | NaN | NaN | 0* |
| Lease impairment (gain on settlement), delray beach facility | NaN | NaN | NaN | -67,498.5* |
| Lease impairment (gain on settlement) | 0 | NaN | NaN | NaN |
| Total operating expenses | 111,137,001 | 182,075,986 | -60,872,275 | 11,009,543.25* |
| Loss from operations | -106,786,267 | -175,364,827 | 69,155,275 | -8,997,764.25* |
| Interest expense, net | 3,683,334 | -3,604,709 | -2,699,383 | -293,428.5* |
| Other income, net | 1,125,771 | 44,606 | 292,230 | -2,685.75* |
| Other expense, net | -2,557,563 | -3,560,103 | -2,407,153 | -296,114.25* |
| Loss on operations before income tax | -109,343,830 | -178,924,930 | 66,748,122 | -9,293,878.5* |
| Income tax benefit (expense) | 0 | 0 | 0 | 0* |
| Net income (loss) from continuing operations | NaN | NaN | 66,748,122 | -9,293,878.5* |
| Interactive offers | NaN | NaN | NaN | 0* |
| Vitamedica | NaN | NaN | NaN | 0* |
| E-core | NaN | NaN | NaN | 0* |
| Gain (loss) from the sale of total | NaN | NaN | NaN | 0* |
| Interactive offers | NaN | NaN | NaN | 0* |
| Vitamedica | NaN | NaN | NaN | 0* |
| E-core | NaN | NaN | NaN | 0* |
| Income (loss) income from discontinued operations | NaN | NaN | NaN | 0* |
| Net loss | -109,343,830 | -178,924,930 | NaN | -9,293,878.5 |
| Basic EPS | -1.67 | -2.94 | 1.21 | -0.429 |
| Diluted EPS | -1.67 | NaN | 0.76 | -0.429 |
| Basic Average Shares | 65,506,837 | 60,829,603 | 55,340,634 | 21,651,946 |
| Diluted Average Shares | 65,506,837 | 60,829,603 | 88,479,950 | 21,651,946 |
UPEXI, INC. (UPXI)
UPEXI, INC. (UPXI)